Cargando…

Access to and use of high blood pressure medications in Brazil

OBJECTIVE: To analyze the access to and use of medicines for high blood pressure among the Brazilian population according to social and demographic conditions. METHODS: Analysis of data from Pesquisa Nacional Sobre Acesso, Utilização e Promoção do Uso Racional de Medicamentos (PNAUM – National Surve...

Descripción completa

Detalles Bibliográficos
Autores principales: Mengue, Sotero Serrate, Bertoldi, Andréa Dâmaso, Ramos, Luiz Roberto, Farias, Mareni Rocha, Oliveira, Maria Auxiliadora, Tavares, Noemia Urruth Leão, Arrais, Paulo Sergio Dourado, Luiza, Vera Lucia, Pizzol, Tatiane da Silva Dal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Faculdade de Saúde Pública da Universidade de São Paulo 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5157910/
https://www.ncbi.nlm.nih.gov/pubmed/27982380
http://dx.doi.org/10.1590/S1518-8787.2016050006154
_version_ 1782481531300741120
author Mengue, Sotero Serrate
Bertoldi, Andréa Dâmaso
Ramos, Luiz Roberto
Farias, Mareni Rocha
Oliveira, Maria Auxiliadora
Tavares, Noemia Urruth Leão
Arrais, Paulo Sergio Dourado
Luiza, Vera Lucia
Pizzol, Tatiane da Silva Dal
author_facet Mengue, Sotero Serrate
Bertoldi, Andréa Dâmaso
Ramos, Luiz Roberto
Farias, Mareni Rocha
Oliveira, Maria Auxiliadora
Tavares, Noemia Urruth Leão
Arrais, Paulo Sergio Dourado
Luiza, Vera Lucia
Pizzol, Tatiane da Silva Dal
author_sort Mengue, Sotero Serrate
collection PubMed
description OBJECTIVE: To analyze the access to and use of medicines for high blood pressure among the Brazilian population according to social and demographic conditions. METHODS: Analysis of data from Pesquisa Nacional Sobre Acesso, Utilização e Promoção do Uso Racional de Medicamentos (PNAUM – National Survey on Access, Use and Promotion of Rational Use of Medicines), a nationwide cross-sectional, population-based study, with probability sampling, carried out between September 2013 and February 2014 in urban households in the five Brazilian regions. The study evaluated the access and use of medicines to treat people with high blood pressure. The independent variables were gender, age, socioeconomic status and Brazilian region. The study also described the most commonly used drugs and the percentage of people treated with one, two, three or more drugs. Point estimations and confidence intervals were calculated considering the sample weights and sample complex plan. RESULTS: Prevalence of high blood pressure was 23.7% (95%CI 22.8–24.6). Regarding people with this condition, 93.8% (95%CI 92.8–94.8) had indication for drug therapy and, of those, 94.6% (95%CI 93.5–95.5) were using the medication at the time of interview. Full access to medicines was 97.9% (95%CI 97.3–98.4); partial access, 1.9% (95%CI 1.4–2.4); and no access, 0.2% (95%CI 0.1–0.4). The medication used to treat high blood pressure, 56.0% (95%CI 52.6–59.2) were obtained from SUS (Brazilian Unified Health System), 16.0% (95%CI 14.3–17.9) from Popular Pharmacy Program, 25.7% (95%CI 23.4–28.2) were paid for by the patients themselves and 2.3% (95%CI 1.8–2.9) were obtained from other locations. The five most commonly used drugs were, in descending order, hydrochlorothiazide, losartan, captopril, enalapril and atenolol. Of the total number of patients on treatment, 36.1% (95%CI 34.1–37.1) were using two medicines and 13.5% (95%CI 12.3–14.9) used three or more. CONCLUSIONS: Access to medicines for the treatment of high blood pressure may be considered high and many of them are available free of charge. The most commonly used drugs are among those recommended as first-line treatment for high blood pressure control. The percentage of people using more than one drug seems to follow the behavior observed in other countries.
format Online
Article
Text
id pubmed-5157910
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Faculdade de Saúde Pública da Universidade de São Paulo
record_format MEDLINE/PubMed
spelling pubmed-51579102016-12-20 Access to and use of high blood pressure medications in Brazil Mengue, Sotero Serrate Bertoldi, Andréa Dâmaso Ramos, Luiz Roberto Farias, Mareni Rocha Oliveira, Maria Auxiliadora Tavares, Noemia Urruth Leão Arrais, Paulo Sergio Dourado Luiza, Vera Lucia Pizzol, Tatiane da Silva Dal Rev Saude Publica Original Articles OBJECTIVE: To analyze the access to and use of medicines for high blood pressure among the Brazilian population according to social and demographic conditions. METHODS: Analysis of data from Pesquisa Nacional Sobre Acesso, Utilização e Promoção do Uso Racional de Medicamentos (PNAUM – National Survey on Access, Use and Promotion of Rational Use of Medicines), a nationwide cross-sectional, population-based study, with probability sampling, carried out between September 2013 and February 2014 in urban households in the five Brazilian regions. The study evaluated the access and use of medicines to treat people with high blood pressure. The independent variables were gender, age, socioeconomic status and Brazilian region. The study also described the most commonly used drugs and the percentage of people treated with one, two, three or more drugs. Point estimations and confidence intervals were calculated considering the sample weights and sample complex plan. RESULTS: Prevalence of high blood pressure was 23.7% (95%CI 22.8–24.6). Regarding people with this condition, 93.8% (95%CI 92.8–94.8) had indication for drug therapy and, of those, 94.6% (95%CI 93.5–95.5) were using the medication at the time of interview. Full access to medicines was 97.9% (95%CI 97.3–98.4); partial access, 1.9% (95%CI 1.4–2.4); and no access, 0.2% (95%CI 0.1–0.4). The medication used to treat high blood pressure, 56.0% (95%CI 52.6–59.2) were obtained from SUS (Brazilian Unified Health System), 16.0% (95%CI 14.3–17.9) from Popular Pharmacy Program, 25.7% (95%CI 23.4–28.2) were paid for by the patients themselves and 2.3% (95%CI 1.8–2.9) were obtained from other locations. The five most commonly used drugs were, in descending order, hydrochlorothiazide, losartan, captopril, enalapril and atenolol. Of the total number of patients on treatment, 36.1% (95%CI 34.1–37.1) were using two medicines and 13.5% (95%CI 12.3–14.9) used three or more. CONCLUSIONS: Access to medicines for the treatment of high blood pressure may be considered high and many of them are available free of charge. The most commonly used drugs are among those recommended as first-line treatment for high blood pressure control. The percentage of people using more than one drug seems to follow the behavior observed in other countries. Faculdade de Saúde Pública da Universidade de São Paulo 2016-12-01 /pmc/articles/PMC5157910/ /pubmed/27982380 http://dx.doi.org/10.1590/S1518-8787.2016050006154 Text en http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Mengue, Sotero Serrate
Bertoldi, Andréa Dâmaso
Ramos, Luiz Roberto
Farias, Mareni Rocha
Oliveira, Maria Auxiliadora
Tavares, Noemia Urruth Leão
Arrais, Paulo Sergio Dourado
Luiza, Vera Lucia
Pizzol, Tatiane da Silva Dal
Access to and use of high blood pressure medications in Brazil
title Access to and use of high blood pressure medications in Brazil
title_full Access to and use of high blood pressure medications in Brazil
title_fullStr Access to and use of high blood pressure medications in Brazil
title_full_unstemmed Access to and use of high blood pressure medications in Brazil
title_short Access to and use of high blood pressure medications in Brazil
title_sort access to and use of high blood pressure medications in brazil
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5157910/
https://www.ncbi.nlm.nih.gov/pubmed/27982380
http://dx.doi.org/10.1590/S1518-8787.2016050006154
work_keys_str_mv AT menguesoteroserrate accesstoanduseofhighbloodpressuremedicationsinbrazil
AT bertoldiandreadamaso accesstoanduseofhighbloodpressuremedicationsinbrazil
AT ramosluizroberto accesstoanduseofhighbloodpressuremedicationsinbrazil
AT fariasmarenirocha accesstoanduseofhighbloodpressuremedicationsinbrazil
AT oliveiramariaauxiliadora accesstoanduseofhighbloodpressuremedicationsinbrazil
AT tavaresnoemiaurruthleao accesstoanduseofhighbloodpressuremedicationsinbrazil
AT arraispaulosergiodourado accesstoanduseofhighbloodpressuremedicationsinbrazil
AT luizaveralucia accesstoanduseofhighbloodpressuremedicationsinbrazil
AT pizzoltatianedasilvadal accesstoanduseofhighbloodpressuremedicationsinbrazil